In patients with corneal astigmatism, a cylindrical defect of about 0.50 diopter (D) to 1.00D may be considered clinically significant, and may influence visual acuity.
be created on the steep axis of the cornea, allowing the cornea to become more rounded in shape when it heals. 11, 12 Nevertheless, there are concerns over the accuracy and predictability of this procedure, [13] [14] [15] [16] with the success of the process dependent upon several factors, including the skill level of the surgeon, depth and position of the cuts, variability of the healing responses, and age of the patient.
An adjunct or alternative to spectacles or the creation of relaxing incisions may be the use of toric intraocular cataract lenses (IOLs).
Implantation of toric IOLs into the eye during cataract surgery may be a more predictable, powerful, and stable way of correcting pre-operative corneal astigmatism. A toric lens is one whose two surfaces differ, with one being spherical in shape and the other being toroidal. Such a shape may allow for the correction of both with-the-rule (WTR) and ATR astigmatism depending on placement of the toroidal axis. 17 Furthermore, toric IOL implantation may be a more effective and predictable treatment option than the creation of relaxing incisions since the former does not require any special surgical skills or instrumentation and tends to be more stable over time.
The Use of Toric Intraocular Lenses to Correct Astigmatism in Cataract Patients
The efficacy and safety of toric IOL implantation for correcting pre-existing corneal astigmatism in patients undergoing cataract surgery has been demonstrated in several studies. [16] [17] [18] [19] [20] [21] Particularly, in a retrospective study that compared toric IOLs with spherical IOLs 
Characteristics of the AcrySof ® IQ Toric Intraocular Lens
The physical characteristics of the AcrySof ® IQ Toric IOL are listed in Table 1 . 22 AcrySof ® IQ Toric IOL has a high refractive index and it can offer various IOL cylinder powers depending on the model used: 1.50D, 2.25D, and 3.00D. The toric IOL has ultraviolet (UV) and blue light filtering properties, with the latter approximating the way in which the human lens filters the 400-475nm blue light wavelength range. The lens has a single-piece aspherical design, with the anterior surface designed with negative spherical aberration to compensate for the positive spherical aberration of the average cornea (see Figure 1) . The lens itself is composed of a soft acrylic material, which means that the lens can be folded prior to insertion into the posterior chamber of the eye through a Toric Intraocular Lenses in Cataract Surgery While there were concerns about post-operative rotation with the earlier versions of toric IOLs, this problem has been substantially reduced with the AcrySof ® Toric IOL. Greater rotational stability facilitates accurate IOL placement and, hence, more predictable visual outcomes. Table 2 demonstrates data for the rotational stability of the AcrySof ® IOL, assessed post-operatively in a prospective study where patients with cataract and pre-existing corneal astigmatism from 1.00 to 2.50D were implanted with bilateral AcrySof ® Toric IOLs. 26 In another study comparing the early rotational stability of two toric IOLs, the mean IOL rotation was significantly lower with the AcrySof ® Toric IOL versus an earlier IOL, AA4203 group (3.35±3.41º versus 5.56±8.49º, respectively; p=0.0232). 20 Additionally, more IOLs in the AcrySof ® IOL group were aligned at or within 5, 10, and 15º when compared with IOLs in the AA4203 group (90, 99, and 100% for the AcrySof ® IOL group versus 70, 90, and 97% for the AA4203 group, respectively).
In a further single-center prospective clinical trial of the AcrySof ® Toric IOL, the results showed a mean misalignment of 3.5º, with no eye having a misalignment greater than 10º. In another study to assess the rotational stability of the AcrySof ® Toric IOL during the first six post-operative months, the mean post-operative IOL rotation was slight:
2.44±1.84º at one month and 2.66±1.99º at six months. These results compare well with those in the above studies of the AcrySof ® Toric IOL and with findings in the US Food and Drug Administration (FDA) trial, which reported a mean rotation of less than 4º. 
Efficacy and Safety of AcrySof ® Toric Intraocular Lens Implantation in Patients Undergoing Surgery
The efficacy and safety of AcrySof ® Toric IOL implantation for correcting pre-existing corneal astigmatism in patients undergoing cataract surgery have been evaluated in a number of clinical trials. 17, 18, 20, 21, 26 In a single-center prospective trial, 53 cataract eyes (43 patients) were implanted with an AcrySof ® Toric IOL. 18 Four months post-operatively, residual refractive astigmatism of less than 0.75D was achieved in 74% of eyes while 91% of the eyes achieved a value of less than 1.00D.
Overall, more than 90% of the eyes achieved a UCVA of 20/40 or better, while a UCVA of 20/25 or better was achieved by almost 80%. there being a significant reduction in the frequency and severity of halos and glares from pre-to post-operative assessment (p<0.05).
It has been earlier noted in this article that there is an increasing demand for distance vision spectacle independence from patients.
Therefore, the effectiveness of new treatment options for corneal astigmatism should be evaluated in terms of whether they improve patient-reported outcomes such as distance vision spectacle independence and patient satisfaction. In the above-mentioned study by Ahmed et al., 26 78 patients were asked to complete a subjective questionnaire pre-operatively and six months post-operatively (see Figure 3) . Importantly, the proportion of patients reported to be spectacle independent for distance vision was significantly greater six 
